Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1997 Nov;81(11):949–952. doi: 10.1136/bjo.81.11.949

Heparinised intraocular infusion and bacterial contamination in cataract surgery

T Manners 1, D Turner 1, P Galloway 1, A Glenn 1
PMCID: PMC1722062  PMID: 9505816

Abstract

BACKGROUND/AIMS—Heparin in solution reduces bacterial adhesion to intraocular lenses and a lower incidence of postoperative endophthalmitis has been reported with the use of heparin coated lenses. The safety of adding low molecular weight heparin to the infusion fluid during routine cataract surgery was investigated. Any direct antibacterial effect was looked for by culturing anterior chamber fluid samples taken at the completion of surgery.
METHODS—A randomised, double blind, controlled study of 111 patients undergoing routine cataract surgery. Low molecular weight heparin at a concentration of 5 IU/ml was added to the infusion fluid in the trial patients. Samples from the anterior chamber taken at completion of surgery were cultured. Twenty nine samples of sterile infusion fluid were also cultured as further controls.
RESULTS—No complications were found in either group, and no difference in observed postoperative inflammation in each group. In the heparinised group (n=55) bacterial contamination was found in 31% of samples, compared with 27% in the no heparin group (n=56) (no significant difference).
CONCLUSIONS—There appears to be no direct antibacterial effect of heparin, and other possible mechanisms of action are discussed. Heparin avoids many of the drawbacks of traditional antibiotic prophylaxis and may have the potential to be a safe and effective addition to endophthalmitis prevention.



Full Text

The Full Text of this article is available as a PDF (80.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alfonso E. C., Flynn H. W., Jr Controversies in endophthalmitis prevention. The risk for emerging resistance to vancomycin. Arch Ophthalmol. 1995 Nov;113(11):1369–1370. doi: 10.1001/archopht.1995.01100110029018. [DOI] [PubMed] [Google Scholar]
  2. Amon M., Menapace R. Long-term results and biocompatibility of heparin-surface-modified intraocular lenses. J Cataract Refract Surg. 1993 Mar;19(2):258–262. doi: 10.1016/s0886-3350(13)80953-4. [DOI] [PubMed] [Google Scholar]
  3. Assalian A., Thompson P., St-Antoine P., Lemire J., Duperré J., Demers J. P., Gauvin P. Anterior chamber fluid contamination after uncomplicated phacoemulsification. J Cataract Refract Surg. 1995 Sep;21(5):539–542. doi: 10.1016/s0886-3350(13)80213-1. [DOI] [PubMed] [Google Scholar]
  4. Boag J. W., Haybittle J. L., Fowler J. F., Emery E. W. The number of patients required in a clinical trial. Br J Radiol. 1971 Feb;44(518):122–125. doi: 10.1259/0007-1285-44-518-122. [DOI] [PubMed] [Google Scholar]
  5. Durán J. A., Malvar A., Rodriguez-Ares M. T., García-Riestra C. Heparin inhibits Pseudomonas adherence to soft contact lenses. Eye (Lond) 1993;7(Pt 1):152–154. doi: 10.1038/eye.1993.32. [DOI] [PubMed] [Google Scholar]
  6. HOGAN M. J., KIMURA S. J., THYGESON P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol. 1959 May;47(5 Pt 2):155–170. doi: 10.1016/s0002-9394(14)78239-x. [DOI] [PubMed] [Google Scholar]
  7. Hughes D. S., Hill R. J. Infectious endophthalmitis after cataract surgery. Br J Ophthalmol. 1994 Mar;78(3):227–232. doi: 10.1136/bjo.78.3.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Iverson D. A., Katsura H., Hartzer M. K., Blumenkranz M. S. Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy. Arch Ophthalmol. 1991 Mar;109(3):405–409. doi: 10.1001/archopht.1991.01080030107048. [DOI] [PubMed] [Google Scholar]
  9. Johnson R. N., Balyeat E., Stern W. H. Heparin prophylaxis for intraocular fibrin. Ophthalmology. 1987 Jun;94(6):597–601. doi: 10.1016/s0161-6420(87)33403-7. [DOI] [PubMed] [Google Scholar]
  10. Johnson R. N., Blankenship G. A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin. Ophthalmology. 1988 Mar;95(3):312–317. doi: 10.1016/s0161-6420(88)33181-7. [DOI] [PubMed] [Google Scholar]
  11. Kohnen T., Dick B., Hessemer V., Jacobi K. W. Anti-inflammatorischer Effekt durch heparinhaltige Infusionslösung während der Phakoemulsifikation. Ophthalmologe. 1995 Jun;92(3):297–302. [PubMed] [Google Scholar]
  12. Larsson R., Selén G., Formgren B., Holst A. Long-term stability of heparin-surface-modified intraocular lenses in vivo. J Cataract Refract Surg. 1992 May;18(3):247–251. doi: 10.1016/s0886-3350(13)80901-7. [DOI] [PubMed] [Google Scholar]
  13. Manners T. D., Chitkara D. K., Marsh P. J., Stoddart M. G. Anterior chamber aspirate cultures in small incision cataract surgery. Br J Ophthalmol. 1995 Oct;79(10):878–880. doi: 10.1136/bjo.79.10.878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Portolés M., Refojo M. F., Leong F. L. Reduced bacterial adhesion to heparin-surface-modified intraocular lenses. J Cataract Refract Surg. 1993 Nov;19(6):755–759. doi: 10.1016/s0886-3350(13)80345-8. [DOI] [PubMed] [Google Scholar]
  15. Sherwood D. R., Rich W. J., Jacob J. S., Hart R. J., Fairchild Y. L. Bacterial contamination of intraocular and extraocular fluids during extracapsular cataract extraction. Eye (Lond) 1989;3(Pt 3):308–312. doi: 10.1038/eye.1989.44. [DOI] [PubMed] [Google Scholar]
  16. Speaker M. G., Milch F. A., Shah M. K., Eisner W., Kreiswirth B. N. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991 May;98(5):639–650. doi: 10.1016/s0161-6420(91)32239-5. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES